{"filing":{"accession_number":"0001213900-26-069407","cik":"0001611747","ticker":"SCNI","company_name":"Scinai Immunotherapeutics Ltd.","form":"6-K","filing_date":"2026-06-17","report_date":null,"primary_document":"ea0295039-6k_scinai.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1611747/000121390026069407/ea0295039-6k_scinai.htm"},"events":[{"id":12420,"run_id":10991,"accession_number":"0001213900-26-069407","anchor_item_number":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The 6-K discloses the results of an Annual Meeting of Shareholders held on June 16, 2026, with detailed voting tallies for eight proposals including director re-elections (Sam Moed, Yael Margolin, Adi Raviv), amendments to Articles of Association, CEO employment agreement amendment, equity grants to the CEO and Chairman, and auditor appointment. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the outcomes are material to investors as they confirm board composition, executive compensation arrangements, and auditor selection.","company_name":"Scinai Immunotherapeutics Ltd.","ticker":"SCNI","filing_date":"2026-06-17","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":9266,"accession_number":"0001213900-26-069407","item_number":null,"item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The 6-K discloses the results of an Annual Meeting of Shareholders held on June 16, 2026, with detailed voting tallies for eight proposals including director re-elections (Sam Moed, Yael Margolin, Adi Raviv), amendments to Articles of Association, CEO employment agreement amendment, equity grants to the CEO and Chairman, and auditor appointment. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the outcomes are material to investors as they confirm board composition, executive compensation arrangements, and auditor selection.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:48:51.733926+00:00","company_name":"Scinai Immunotherapeutics Ltd.","ticker":"SCNI","filing_date":"2026-06-17"}]}